1. Home
  2. LFMD vs DCTH Comparison

LFMD vs DCTH Comparison

Compare LFMD & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • DCTH
  • Stock Information
  • Founded
  • LFMD 1994
  • DCTH 1988
  • Country
  • LFMD United States
  • DCTH United States
  • Employees
  • LFMD N/A
  • DCTH N/A
  • Industry
  • LFMD Medical/Nursing Services
  • DCTH Medical/Dental Instruments
  • Sector
  • LFMD Health Care
  • DCTH Health Care
  • Exchange
  • LFMD Nasdaq
  • DCTH Nasdaq
  • Market Cap
  • LFMD 330.5M
  • DCTH 388.3M
  • IPO Year
  • LFMD N/A
  • DCTH N/A
  • Fundamental
  • Price
  • LFMD $4.66
  • DCTH $8.94
  • Analyst Decision
  • LFMD Buy
  • DCTH Strong Buy
  • Analyst Count
  • LFMD 6
  • DCTH 5
  • Target Price
  • LFMD $12.50
  • DCTH $22.60
  • AVG Volume (30 Days)
  • LFMD 884.2K
  • DCTH 1.2M
  • Earning Date
  • LFMD 11-17-2025
  • DCTH 11-04-2025
  • Dividend Yield
  • LFMD N/A
  • DCTH N/A
  • EPS Growth
  • LFMD N/A
  • DCTH N/A
  • EPS
  • LFMD N/A
  • DCTH 0.03
  • Revenue
  • LFMD $245,563,670.00
  • DCTH $79,603,000.00
  • Revenue This Year
  • LFMD $21.50
  • DCTH $135.11
  • Revenue Next Year
  • LFMD $17.18
  • DCTH $36.30
  • P/E Ratio
  • LFMD N/A
  • DCTH $260.68
  • Revenue Growth
  • LFMD 37.74
  • DCTH 251.54
  • 52 Week Low
  • LFMD $4.13
  • DCTH $8.33
  • 52 Week High
  • LFMD $15.84
  • DCTH $18.23
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 22.99
  • DCTH 38.02
  • Support Level
  • LFMD $4.97
  • DCTH $8.33
  • Resistance Level
  • LFMD $5.17
  • DCTH $8.82
  • Average True Range (ATR)
  • LFMD 0.28
  • DCTH 0.51
  • MACD
  • LFMD -0.10
  • DCTH -0.04
  • Stochastic Oscillator
  • LFMD 7.12
  • DCTH 32.70

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: